Genovis
Genovis to receive USD 1 million in milestone compensation related to the development of the Xork™ enzyme
REG
Xork is derived from a streptococcal bacterial strain that does not infect humans. The pre-clinical data generated to date highlights Xork's differentiated profile demonstrating very low cross-reactivity with naturally occurring antibodies in human sera while retaining efficient and specific cleavage of human IgG antibodies.
Datum | 2024-02-13, kl 08:20 |
Källa | Cision |
![](https://static.allaaktier.se/ads/hand-waving-2.png)